{"url_path":"/sec/gyro/10-q/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1589061/0001437749-26-016537-index.html","accession_number":"0001437749-26-016537","cik":"0001589061","ticker":"GYRO","issuer_name":"Gyrodyne, LLC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1589061/0001437749-26-016537-index.html","primary_entity_key":"0001589061","primary_entity_name":"Gyrodyne, LLC"},"word_count":579,"has_tables":true,"body_markdown":"gyrllc20260331_10q.htm\n\nQ1\n2026\n--12-31\nfalse\n0001589061\n2\n2\n3\n0\n0\n1\n2023 2024 2025\n2\n2\n3\n2\n5\n5\n2\n\n00015890612026-01-012026-03-31\nthunderdome:item\nxbrli:pure\n00015890612026-03-31\nutr:Y\n00015890612023-10-122023-10-12\n00015890612025-01-012025-12-31\n00015890612024-01-012024-12-31\n00015890612023-01-012023-12-31\n00015890612022-01-012022-12-31\n00015890612021-01-012021-12-31\n00015890612020-01-012020-12-31\n00015890612020-01-01\nxbrli:shares\n0001589061us-gaap:RestrictedStockMember2026-01-012026-03-31\n0001589061us-gaap:RestrictedStockMembergyro:Director4Member2026-01-012026-03-31\n0001589061us-gaap:RestrictedStockMembergyro:Director3Member2026-01-012026-03-31\n0001589061us-gaap:RestrictedStockMembergyro:Director2Member2026-01-012026-03-31\n0001589061us-gaap:RestrictedStockMembergyro:Director1Member2026-01-012026-03-31\n0001589061gyro:StockPlanMember2023-11-142023-11-14\n0001589061gyro:RightsOfferingMember2023-11-142023-11-14\n0001589061gyro:StockPlanMember2023-11-14\n0001589061srt:DirectorMember2023-09-052023-09-05\niso4217:USD\n0001589061srt:OfficerMember2026-03-31\n0001589061srt:ChiefOperatingOfficerMember2026-03-31\n0001589061srt:ChiefExecutiveOfficerMember2026-03-31\nutr:M\n0001589061srt:ChiefOperatingOfficerMember2026-01-012026-03-31\n0001589061srt:ChiefExecutiveOfficerMember2026-01-012026-03-31\n0001589061gyro:BonusPayableMembersrt:ChiefExecutiveOfficerMember2025-12-31\n0001589061gyro:ManagementEmploymentAgreementsWithBonusAndSeveranceCommitmentContingenciesMember2025-12-31\n0001589061gyro:RentalIncomeMemberus-gaap:CustomerConcentrationRiskMembergyro:TenantThreeMember2026-01-012026-03-31\n0001589061gyro:RentalIncomeMemberus-gaap:CustomerConcentrationRiskMembergyro:TenantTwoMember2026-01-012026-03-31\n0001589061gyro:RentalIncomeMemberus-gaap:CustomerConcentrationRiskMembergyro:TenantOneMember2026-01-012026-03-31\n0001589061us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembergyro:OneOfLargestTenantsMember2026-03-31\n0001589061us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMembergyro:OneOfLargestTenantsMember2026-01-012026-03-31\n0001589061us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2026-01-012026-03-31\n00015890612024-12-31\n00015890612025-12-31\n0001589061gyro:InvoicePayableStarting2025Member2025-01-01\n0001589061gyro:InvoicePayableThrough2024Member2024-12-31\n00015890612024-02-022024-02-02\n00015890612024-02-012024-02-01\n0001589061gyro:MortgageLoanMember2026-01-01\n0001589061gyro:MortgageLoanMember2026-01-012026-01-01\n0001589061gyro:MortgageLoanMember2023-12-27\n0001589061gyro:MortgageLoanMemberus-gaap:PrimeRateMember2023-12-272023-12-27\n0001589061gyro:MortgageLoanMember2023-12-272023-12-27\nutr:acre\n0001589061us-gaap:AssetPledgedAsCollateralMembergyro:CortlandtManorMedicalCenterMember2026-03-31\n0001589061gyro:TermLoanMember2026-03-31\n0001589061gyro:TermLoanMembergyro:IfMaturityDateIsExtendedMember2021-09-15\n0001589061gyro:ExtendedTermLoanMemberus-gaap:UsTreasuryUstInterestRateMember2021-09-152021-09-15\n0001589061gyro:ExtendedTermLoanMember2021-09-15\n0001589061gyro:NonrevolvingCreditLine3Membergyro:TermLoanMember2021-09-152021-09-15\n0001589061gyro:NonrevolvingCreditLine3Member2021-09-152021-09-15\n0001589061gyro:TermLoanMember2021-09-15\n0001589061gyro:RealEstateSecuringMortgageLoanMembergyro:FlowerfieldIndustrialParkMember2026-03-31\n0001589061gyro:NonrevolvingCreditLine2Member2026-03-31\n0001589061gyro:NonrevolvingCreditLine2Membergyro:AfterInterestOnlyPaymentPeriodMember2019-01-242019-01-24\n0001589061gyro:NonrevolvingCreditLine2Membergyro:AfterInterestOnlyPaymentPeriodMembersrt:MinimumMembergyro:FederalHomeLoanBankRateMember2019-01-242019-01-24\n0001589061gyro:NonrevolvingCreditLine2Member2021-05-20\n0001589061gyro:NonrevolvingCreditLine2Member2019-01-24\n0001589061gyro:NonrevolvingCreditLineMember2026-03-31\n0001589061gyro:NonrevolvingCreditLineMembergyro:AfterInterestOnlyPaymentPeriodMembergyro:FederalHomeLoanBankRateMember2021-04-012021-04-01\n0001589061gyro:NonrevolvingCreditLineMembergyro:AfterInterestOnlyPaymentPeriodMembersrt:MinimumMembergyro:FederalHomeLoanBankRateMember2021-04-302021-04-30\n0001589061gyro:NonrevolvingCreditLineMember2021-04-30\n0001589061gyro:NonrevolvingCreditLineMember2018-03-21\n0001589061gyro:StJamesFlowerfieldComplexMembergyro:StJamesNewYorkMember2026-01-06\nutr:D\n0001589061gyro:StJamesFlowerfieldComplexMembergyro:StJamesNewYorkMember2025-07-302025-07-30\n0001589061gyro:StJamesFlowerfieldComplexMembergyro:StJamesNewYorkMember2025-07-30\n0001589061srt:MaximumMembergyro:StJamesFlowerfieldComplexMembergyro:StJamesNewYorkMember2025-07-30\n0001589061srt:MinimumMembergyro:StJamesFlowerfieldComplexMembergyro:StJamesNewYorkMember2025-07-30\n0001589061gyro:ApproximateMember2026-03-31\niso4217:USDxbrli:shares\n0001589061srt:ScenarioForecastMember2026-04-012026-12-31\n00015890612015-09-012015-09-01\nutr:sqft\n0001589061gyro:MultiTenantIndustrialParkMembergyro:FlowerfieldPropertiesIncMembergyro:StJamesNewYorkMember2026-03-31\n0001589061gyro:FlowerfieldPropertiesIncMembergyro:StJamesNewYorkMembergyro:ControlledByParentCompanyMember2026-03-31\n0001589061gyro:CortlandtManorMedicalCenterMembergyro:CortlandtNewYorkMember2026-03-31\n0001589061gyro:TheCorporationMember2026-01-012026-03-31\n0001589061gyro:RetailUseMembergyro:CortlandtManorMedicalCenterMembergyro:CortlandtNewYorkMember2023-03-20\n0001589061gyro:MedicalUseMembergyro:CortlandtManorMedicalCenterMembergyro:CortlandtNewYorkMember2023-03-20\n0001589061gyro:CortlandtManorMedicalCenterMembergyro:CortlandtNewYorkMember2023-03-20\n00015890612026-05-13\n\n \n\n \n\n \n\n**FORM 10-Q**\n\n \n\nSECURITIES AND EXCHANGE COMMISSION\n\nWashington, D.C. 20549\n\n(Mark One)\n\n**☒**         QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\n\nFor the quarterly period ended March 31, 2026\n\n \n\nOR\n\n \n\n**☐**         TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\n\nFor the transition period from ____________ to ____________\n\n \n\nCommission file number **001-37547**\n\n**Gyrodyne, LLC**\n\n(Exact name of registrant as specified in its charter)\n\n \n\nNew York\n46-3838291\n\n(State or other jurisdiction of incorporation or organization)\n(I.R.S. Employer Identification No.)\n\n \n\n1 Flowerfield, Suite 24, St. James, NY 11780\n\n(Address and Zip Code of principal executive offices)\n\n \n\n(631) 584-5400\n\n(Registrant’s telephone number, including area code)\n\n \n\n(Former name, former address and former fiscal year, if changed since last report)\n\n \n\nSecurities registered pursuant to Section 12(b) of the Act:\n\n \n\n**Title of Each Class**\n\n**Trading Symbol**\n\n**Name of Exchange on which Registered**\n\nCommon Shares of Limited Liability Company Interests\n\nGYRO\n\nNasdaq Capital Market\n\n \n\nIndicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  ☒    No  ☐\n\n \n\nIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  ☒    No  ☐\n\n \n\nIndicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.\n\n \n\nLarge accelerated filer  ☐\nAccelerated filer  ☐\n\nNon-accelerated filer  ☒\nSmaller reporting company  ☒\n\nEmerging growth company  ☐\n \n\n \n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐\n\n \n\nIndicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  ☐    No  ☒\n\n \n\nIndicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.\n\n \n\nOn May 13, 2026, there were 2,199,308 common shares outstanding.\n\n \n\n1\n\n \n\n \n\n \n\nINDEX TO QUARTERLY REPORT OF GYRODYNE, LLC\n\nQUARTER ENDED MARCH 31, 2026\n\n \n\n \n\n \nSeq. Page\n\n \n \n\nForm 10-Q Cover\n\n1\n\n \n \n\nIndex to Form 10-Q\n\n2\n\n \n \n\nPART I - FINANCIAL INFORMATION\n\n3"}